Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Muñoz-Torrero

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|February 10, 2009
Exploiting multivalency in drug designDiego Muñoz-Torrero
Current Medicinal Chemistry|March 6, 2013
Complexity against complexity: multitarget drugsDiego Muñoz-Torrero
Molecules (Basel, Switzerland)|March 6, 2021
The Cream of the Crop of the Medicinal Chemistry Section of <i>Molecules</i>-2019Diego Muñoz-Torrero
Expert Opinion on Drug Discovery|March 14, 2013
Huprines for Alzheimer's disease drug developmentDiego Muñoz-Torrero, Pelayo Camps
Molecules (Basel, Switzerland)|December 22, 2016
Special Issue: "Molecules against Alzheimer"Michael Decker, Diego Muñoz-Torrero
Accounts of Chemical Research|February 9, 2024
Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic TargetsF Javier Luque, Diego Muñoz-Torrero
Current Topics in Medicinal Chemistry|August 13, 2013
Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidatesElisabet Viayna, Raimon Sabate, Diego Muñoz-Torrero
Chemical Research in Toxicology|January 4, 2023
Chlorpyrifos Oxon Activates Glutamate and Lysine for Protein Cross-linkingDiego Muñoz-Torrero, Lawrence M Schopfer, Oksana Lockridge
European Journal of Medicinal Chemistry|November 27, 2015
A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systemsSusanna Navarro, Anita Carija, Diego Muñoz-Torrero, et al.
ACS Chemical Neuroscience|November 2, 2018
Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational DiseasesAlba Espargaró, Caterina Pont, Patrick Gamez, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|February 10, 2009
Exploiting multivalency in drug designDiego Muñoz-Torrero
Current Medicinal Chemistry|March 6, 2013
Complexity against complexity: multitarget drugsDiego Muñoz-Torrero
Molecules (Basel, Switzerland)|March 6, 2021
The Cream of the Crop of the Medicinal Chemistry Section of <i>Molecules</i>-2019Diego Muñoz-Torrero
Expert Opinion on Drug Discovery|March 14, 2013
Huprines for Alzheimer's disease drug developmentDiego Muñoz-Torrero, Pelayo Camps
Molecules (Basel, Switzerland)|December 22, 2016
Special Issue: "Molecules against Alzheimer"Michael Decker, Diego Muñoz-Torrero
Accounts of Chemical Research|February 9, 2024
Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic TargetsF Javier Luque, Diego Muñoz-Torrero
Current Topics in Medicinal Chemistry|August 13, 2013
Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidatesElisabet Viayna, Raimon Sabate, Diego Muñoz-Torrero
Chemical Research in Toxicology|January 4, 2023
Chlorpyrifos Oxon Activates Glutamate and Lysine for Protein Cross-linkingDiego Muñoz-Torrero, Lawrence M Schopfer, Oksana Lockridge
European Journal of Medicinal Chemistry|November 27, 2015
A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systemsSusanna Navarro, Anita Carija, Diego Muñoz-Torrero, et al.
ACS Chemical Neuroscience|November 2, 2018
Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational DiseasesAlba Espargaró, Caterina Pont, Patrick Gamez, et al.
Pageof 9